Supplementary Data from Circulating and intratumoral immune determinants of response to atezolizumab plus bevacizumab in patients with variant histology or sarcomatoid renal cell carcinoma
Key Points
Key points are not available for this paper at this time.
Abstract
Titles and captions of supplementary figures
AI से पूछें
Like
Bookmark
Share
AI से पूछें
Like
Bookmark
Share
Supplementary Data from Circulating and intratumoral immune determinants of response to atezolizumab plus bevacizumab in patients with variant histology or sarcomatoid renal cell carcinoma | Synapse